- Companies
- Alice
Alice Funding, Investors & Competitors
Alice has raised $238M across 6 funding rounds, most recently a $40M Series D in October 2026.
Last Alice funding round
$40M
Series D · Oct 2026
Alice revenue
$80M
Series C · Feb 2025
Key investors in Alice
Kaszek
Canary
ThornTree Capital Partners
MAYA Capital
Globo Ventures
SoftBank Group
Bossa Invest
Endeavor Catalyst
About Alice
Alice is a Brazilian health plan operator based in Sao Paulo that sells employer-paid health plans built around primary care. It was founded in 2019 by Andre Florence, Matheus Moraes and Guilherme Azevedo and is registered with the national health regulator. Each member has a dedicated health team that coordinates care across a network of hospitals, laboratories and specialists, with health data kept in one record. By February 2025 it had about 42,000 members in 12,000 companies and annualised revenue of R$465 million. It first sold individual plans and since 2023 serves only companies. Investors include Kaszek, ThornTree Capital Partners, Canary, SoftBank and Globo Ventures, and it raised US$127 million in a Series C in December 2021 and a US$22 million extension in February 2025. In November 2021 it bought the corporate health startup Cuidas, whose founders joined Alice.
Founded
2019
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Subscription
Revenue
$80M (Feb 2025)
Alice Revenue
Alice's latest recorded revenue is $80M, as of its Series C in February 2025.
Alice revenue by funding round
| Date | Revenue * | Stage |
|---|---|---|
| Feb 2025 | $80M | Series C |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Alice Funding History
Alice has raised a total of $238M across 6 funding rounds.
Alice's first fundraising round was a seed round in July 2019. The most recent completed round was a $40M Series D in October 2026.
Alice funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Oct 2026 | Series D | International Finance Corporation (lead); KFW DEG; Canary; ThornTree Capital Partners; Kaszek; Finnfund | $40M | Alice, the Brazilian corporate health plan, raised a USD 40 million Series D in October 2026, led by the International Finance Corporation, the private-sector arm of the World Bank Group. Germany's DEG and Finland's Finnfund joined the round, alongside existing backers Kaszek, ThornTree Capital and Canary. It is the company's first equity round since its USD 127 million Series C, which SoftBank led in 2021; SoftBank did not take part in the new round, sold part of its stake to Canary and has left the board. The company said the proceeds will fund expansion and deeper use of artificial intelligence across its insurance and medical services, including the planned rollout of an in-app assistant, Alice AI, to all members in November 2026. Alice describes itself as an AI company that operates a health plan and combines plan administration, medical records and clinical services in one operating structure. It sells employer-sponsored health plans in Brazil and serves more than 100,000 members, up from about 6,000 clients at the time of the Series C. The company reports that AI has cut care operating costs by 18 percent and waiting times by 12.5 percent, and it targets administrative costs near 2 percent of revenue over the long term. André Florence is co-founder and chief executive. |
| Feb 2025 | Series C | Kaszek (lead); Globo Ventures; Canary; ThornTree Capital Partners | $22M | Alice announced a US$22 million extension of its Series C round in February 2025, more than three years after the US$127 million Series C of December 2021. The extension was led by existing investors Kaszek, ThornTree Capital Partners, Canary and Globo Ventures. Alice operates employer-paid health plans in Brazil, with about 42,000 members across 12,000 companies and annualised revenue of R$465 million at the time. The company has raised more than R$1 billion since its creation in 2019 and works with over a thousand hospitals, 4,000 laboratories and 10,000 specialists and clinics. In 2023 it had moved away from individual plans to serve only small, medium and large companies, and it took over a book of members from another operator. For 2025 it aimed to reach 70,000 members and R$600 million of revenue while keeping its medical loss ratio at 68 per cent. Management said the extension was meant to strengthen the business and that no further rounds were expected soon. |
| Dec 2021 | Series C | SoftBank Group (lead); StepStone Group; Globo Ventures; ThornTree Capital Partners; Kaszek; G Squared; Allen & Company | $127M | Alice is a Brazilian healthtech company that operates on a B2B model, providing health services as a benefit to corporate employees. The company manages health services for more than 6,000 corporate customers through an affiliated network of ten hospitals, approximately 200 laboratories, and 150 medical specialists, primarily in the São Paulo metropolitan region. The company was created in response to health challenges exacerbated by the Covid-19 pandemic and offers online medical consultations throughout Brazil. In December 2021, Alice closed a Series C funding round of $127 million led by SoftBank Latin America Fund, making it the largest funding round yet for a healthtech startup in Latin America. The round also included previous investors Kaszek Ventures and ThornTree Capital Partners, as well as new investors Allen & Company LLC, G Squared, Globo Ventures, and StepStone, with existing shareholders Canary, Endeavor Catalyst, and Maya Capital remaining invested. The company used the new capital to invest in technology and expand its service offerings. Alice also acquired Cuidas, another corporate health company specializing in small and medium-sized business customers, with an estimated market of more than 5 million members in São Paulo alone. |
| Feb 2021 | Series B | ThornTree Capital Partners (lead); Canary; Kaszek; IKJ Capital; Endeavor Catalyst; MAYA Capital; Bossa Invest | $33M | Alice is a Brazilian healthtech company founded in 2019 by Andre Florence, Matheus Moraes (alums of 99), and Guilherme Azevedo (Dr. Consulta), providing corporate health plans focused on primary care, care coordination, and technology. In February 2021, ThornTree Capital Partners led a Series B round of $33.3 million (R$180 million), with participation from investors including Bossa Invest, Canary, Endeavor Catalyst, IKJ Capital, Kaszek, and MAYA Capital. This followed a $16 million (US$16m) investment in 2020 from Canary, Kaszek Ventures, and MAYA Capital. The round aimed to address healthcare needs in Brazil's population. Later in December 2021, Alice raised $127 million in a Series C round led by SoftBank, with participation from Kaszek, ThornTree Capital Partners, Allen & Co., G. Squared, Globo Ventures, and StepStone, marking the largest funding for a healthtech in Latin America at the time. Previous investors like Maya Capital, Canary, and Endeavor Catalyst remained shareholders. Total funding across rounds reached approximately $176 million by late 2021. With proceeds from later funding, Alice planned to accelerate technology investments and expand to small and medium-sized corporate customers, including through the acquisition of rival startup Cuidas in November 2021, which specialized in that segment and had raised $4 million from investors like Jorge Paulo Lemann and Abilio Diniz. The company operated in a competitive market with complex regulations, positioning itself for long-term health management results. |
| Jun 2020 | Series A | Kaszek (lead); Canary; MAYA Capital | $16M | Alice is a Brazilian healthcare provider founded by André Florence, Matheus Moraes, and Guilherme Azevedo. The company offers a proprietary care model delivered in person and digitally by a health team, combined with B2C integrated health insurance. It features a tech-integrated network of providers inspired by primary care, coordinating members across the health system with centralized health data. Canary, Kaszek Ventures, and MAYA Capital invested a total of US$16 million in Alice prior to its launch in Sao Paulo in the second semester of 2020. Alice first raised from Canary, followed by a Series A round led by Kaszek Ventures, with MAYA Capital and Canary as additional investors. The funding supported the development of its health action plans monitored by dedicated teams. The company had been in development for 15 months as of July 2020 and is registered with Brazil's National Health Agency (ANS). |
| Jul 2019 | Seed | Canary (lead) | - | Canary, a Brazilian venture capital fund, made the first investment in Alice in 2019, shortly after the company was founded. Alice was started by Andre Florence and Matheus Moraes, both formerly of the ride-hailing company 99, and Guilherme Azevedo, a co-founder of the clinic network dr.consulta. The company set out to build a health plan around primary care, with a dedicated health team coordinating each member across hospitals, laboratories and doctors, and with all health data kept in one electronic record. It spent about 15 months in development and registered with the national health regulator before launching in Sao Paulo in the second half of 2020. The size of the seed round was not published. Canary was followed by a Series A led by Kaszek in 2020, and altogether the company had raised US$16 million before it opened to customers. |
Who has invested in Alice?
15 investors have backed Alice across its funding rounds, including Kaszek, Canary, ThornTree Capital Partners, MAYA Capital, Globo Ventures and SoftBank Group.
Lead investors include International Finance Corporation, Kaszek, SoftBank Group, ThornTree Capital Partners and Canary.
Alice Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 5 | Lead | Jul 2019 | ||
| 5 | Lead | Jun 2020 | ||
| 4 | Lead | Feb 2021 | ||
| 2 | Participant | Dec 2021 | ||
| 2 | Participant | Jun 2020 | ||
| 1 | Participant | Oct 2026 | ||
| 1 | Participant | Dec 2021 | ||
| 1 | Lead | Dec 2021 | ||
| 1 | Participant | Dec 2021 | ||
| 1 | Participant | Feb 2021 | ||
| 1 | Participant | Feb 2021 | ||
| 1 | Lead | Oct 2026 | ||
| 1 | Participant | Dec 2021 | ||
This data is available for Pro users. Sign up to see all 15 Alice investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Alice
Alice has acquired 1 company to date.
Last acquisition by Alice was on November 23rd 2021. Alice acquired Cuidas for undisclosed valuation.
Latest Acquisitions by Alice
| Description | Cuidas is a Sao Paulo-based health tech company founded in 2018 that links corporate employees to primary care physicians via teleconsultations and in-clinic visits. Operating in over 200 companies across Brazil, it manages chronic conditions like hypertension through its app, which schedules appointments and tracks prescriptions. The platform partners with health insurers such as Bradesco Saude, serving 100,000 patients annually in Sao Paulo, Rio de Janeiro, and Belo Horizonte with 24/7 virtual support. |
| HQ Country | |
| HQ City | São Paulo |
| Deal Date | 23 Nov 2021 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Alice acquisitions and their M&A valuation multiples. Start Free Trial | |
Alice Competitors
Alice competitors include listed companies like Clover Health and CCC Intelligent Solutions, and private ones like Cityblock Health, Aledade, Somatus and Strive Health.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $2.2B | - | $5.7B | - | ||
| Private | $475M | - | $3.5B | 7.4x | ||
| Publicly listed | $1.9B | ($84M) | $2.6B | 0.9x | ||
| Private | - | - | $2.5B | - | ||
| Private | - | - | $1.8B | - | ||
| Publicly listed | $1.1B | $238M | $4.5B | 4.0x |
Alice Public Comps
Alice is still privately-owned, but its public comps include UnitedHealth Group, IDEXX Laboratories, Veeva, Roper Technologies, IQVIA, GE HealthCare, ICON plc, Pro Medicus, United Imaging and Glaukos.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $448B | $23B | 0.9x | 0.9x | 17.6x | 13.4x | |||
| $4.3B | $1.5B | 12.6x | 11.5x | 35.9x | 32.3x | |||
| $3.2B | $965M | 13.2x | 11.8x | 43.6x | 25.9x | |||
| $7.9B | $3.2B | 7.2x | 6.7x | 17.9x | 17.0x | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.7x | |||
| $21B | $3.7B | 2.2x | 2.1x | 12.0x | 11.6x | |||
| $8.3B | $816M | 2.2x | 2.2x | 22.1x | 13.3x | |||
| $181M | $143M | 81.0x | 72.5x | 102.6x | 90.2x | |||
This data is available for Pro users. Sign up to see all Alice competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Alice
| When was Alice founded? | Alice was founded in 2019. |
| Where is Alice headquartered? | Alice is headquartered in São Paulo, Brazil. |
| Is Alice publicly listed? | No, Alice is a private, VC-backed company. |
| How much funding has Alice raised? | Alice has raised $238M across 6 funding rounds. |
| What was Alice's last funding round? | Alice's last funding round was a $40M Series D in October 2026, led by International Finance Corporation. |
| Who are Alice's investors? | Alice's investors include Canary, Kaszek, ThornTree Capital Partners, Globo Ventures, MAYA Capital, KFW DEG, StepStone Group, SoftBank Group, G Squared, IKJ Capital and 5 others. |
| What is Alice's revenue? | Alice's latest recorded revenue is $80M (February 2025). |
| Which companies are comparable to Alice? | Companies comparable to Alice include Cityblock Health, Aledade, Clover Health, Somatus, Strive Health and CCC Intelligent Solutions. |
| How many companies has Alice acquired? | Alice has acquired 1 company, including Cuidas. |
See companies similar to Alice
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




